“A large amount of fructose is metabolized in the liver and causes hepatic functional damage. Δ9 -tetrahydrocannabinol (THC) is known as a therapeutic agent for clinical and experimental applications.
The study aims to investigate the effects of THC treatment on inflammation, lipid profiles and oxidative stress in rat liver with hyperinsulinemia.
According to the result, long-term and low-dose THC administration may reduce hyperinsulinemia and inflammation in rats to some extent.”
https://www.ncbi.nlm.nih.gov/pubmed/30427077
https://onlinelibrary.wiley.com/doi/abs/10.1111/jphp.13042
